Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long‐term follow‐up of the <scp>EORTC‐GIMEMA</scp> randomized <scp>AML</scp>‐10 trial-Reference-Cited by-同舟云学术

Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long‐term follow‐up of the EORTC‐GIMEMA randomized AML‐10 trial

Published:2024-01-04 Issue:3 Volume:99 Page:486-489
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Baron Frédéric¹^ORCID,Efficace Fabio²^ORCID,Cannella Laura²,Stevens‐Kroef Marian³,Amadori Sergio²,de Witte Theo³,Lübbert Michael⁴,Venditti Adriano⁵^ORCID,Suciu Stefan⁶

Affiliation:

1. Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Laboratory of Hematology University of Liège Liège Belgium

2. Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA Rome Italy

3. Radboud University Medical Center Nijmegen The Netherlands

4. Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine University Medical Center Freiburg, University of Freiburg Freiburg Germany

5. Department of Hematology Sapienza University Rome Italy

6. EORTC Headquarters Brussels Belgium

Funder

Stichting Tegen Kanker

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27196

Reference6 articles.

1. Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey

2. Higher Incidence of Relapse With Peripheral Blood Rather Than Marrow As a Source of Stem Cells in Adults With Acute Myelocytic Leukemia Autografted During the First Remission

3. Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long‐term follow up of a phase III study

4. High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT

5. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials